PolTREG S.A.’s Post

Prof. Piotr Trzonkowski among the top 100 medical leaders in Poland! We are pleased to announce that Prof. Piotr Trzonkowski, CEO and Co-Founder of PolTREG, has been ranked 26th among the 100 most influential figures in Polish medicine in the prestigious ranking by Puls Medycyny. A global pioneer in TREG cell therapy, Prof. Trzonkowski and his team were the first in the world to administer TREG therapy to a patient. This achievement has allowed PolTREG to accumulate nearly 20 years of experience in this area. In addition to his role at PolTREG, Prof. Trzonkowski serves as the Head of the Department of Medical Immunology at the Gdański Uniwersytet Medyczny (Medical University of Gdańsk). The ranking included also Prof. Małgorzata Myśliwiec from of the Department of Pediatric Diabetology and Endocrinology at the Gdański Uniwersytet Medyczny (Medical University of Gdańsk), co-inventor of TREG therapy in type 1 diabetes and co-Founder and long-term collaborator of PolTREG. PolTREG is the only company worldwide with over 10 years of patient safety and efficacy data for autologous polyclonal TREG therapies, obtained from clinical trials and hospital exemptions in Poland. The complete list is available here: https://lnkd.in/dyYVZdRr #T1D #biotech #biotechnology #celltherapy #cellandgenetherapy #autoimmunedisease #diabetes #type1diabetes #multiplesclerosis